Her research focus is on psychosis and schizophrenia intending to find predictors and mechanisms for mental illness.
[1][2] Addington studies individuals at high risk of developing psychosis and people in the first stages of a psychotic illness.
One goal of her research is to predict which people will convert to psychosis, which are individuals who are typically in their late teens and early twenties.
[3] Addington holds the Novartis Chair for Schizophrenia Research at the University of Calgary and became a Fellow of the Royal Society of Canada in 2020.
[1] She also received the Richard J. Wyatt Award from the International Association for Early Intervention in Mental Health in 2020.